Know Where Vablys Fits in the Treatment of Bacterial Vaginosis

August 2022

You’ll see Vablys (dequalinium chloride), a new Rx vaginal med for treating bacterial vaginosis (BV) in adults under age 55.

These infections are caused by an overgrowth of certain bacteria in the vagina.

Vablys will be promoted as the first intravaginal “antiseptic”...with the idea that it may have improved coverage of resistant bacterial strains.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cultural Awareness Help Investigate Whether a Med Is Derived From Animals
OTC Products Stay Alert for Patients Getting Lumify for Red Eyes
Heart Failure Minimize Mishaps With Heart Failure Meds
Vaginal Infections Know Where Vablys Fits in the Treatment of Bacterial Vaginosis
Recalls Work as a Team to Handle Drug Recalls
Supplements Sort Through Supplements for Osteoarthritis
Communication Promote Respect Among Colleagues
Oral Health Be Familiar With Treatments for Canker and Cold Sores
Statins Help Patients Stick With a Statin